Clinical Trials

MedNews is a FREE SERVICE of Medical and Pharma Insider in conjunction with BCI News Service.

To have your company news featured at Medical and Pharma Insider, please visit www.bcinewsservice.com.

View our disclaimer/disclosure

Featuring MedNews and MedTalks Videos, video conversations with management of medical, pharma, biopharma, healthcare, telemedicine, and medical device companies.

Nov 23
3 min

scPharmaceuticals Announces Pricing of $50 Million Public Offering

scPharmaceuticals is a clinical-stage pharmaceutical company focused on developing and commercializing products that have the potential...

Nov 5
3 min

H.I.G. Capital acquires leading global clinical research organization Celerion

Headquartered in Lincoln, NE, Celerion is a leading global clinical research organization focused on providing end-to-end early stage clinic

Oct 15
4 min

Integrated Drug Development Solution Company Altasciences Expands Support for Early Drug Development

The company is focused on innovative targeted radiopharmaceuticals for the diagnosis, monitoring, and therapy of cancer.

Oct 8
4 min

RadioMedix raises $40 million to advance its alpha therapy platform for oncology

Targeted alpha therapies are currently considered one of the most advanced technologies available to treat patients with incurable cancers.

Oct 2
4 min

CXL Ophthalmics announces $32 Million investment to advance its treatment for keratoconus

“EpiSmart has the potential to be a game-changer for the treatment for keratoconus.

Sep 28
3 min

Aqualung Therapeutics Receives FDA Clearance of its IND for Acute Respiratory Distress Syndrome

Aqualung is an early-stage biotech company developing immune-focused therapeutic platform, eNamptor™.

Sep 27
2 min

SeraNovo and Ildong Pharmaceutical to Collaborate on Multi-Compound Research Projects

Our team is addressing two core issues with our proprietary technology: enhancing bioavailability and reducing development time.

Sep 1
3 min

OKYO plans fourth quarter IND filing for drug candidate to treat dry eye disease

OKYO Pharma Limited (NASDAQ: OKYO; LSE: OKYO) is a life sciences and biotechnology company recently listed on Nasdaq .

Aug 13
2 min

Clario invests in new technology to reduce translation times for clinical trials

For nearly 50 years, Clario has been delivering the leading endpoint technology solutions for clinical trials.

Aug 5
2 min

Immunis Closes $10 Million to advance its immunomodulatory secretome product for muscle atrophy

Immunis’ FDA Phase 1/2a clinical trial is a study to assess IMM01-STEM in elderly participants with muscle atrophy.

Aug 3
3 min

IDRx raises $122 million to transform cancer treatment with precision combination therapies

IDRx is a clinical-stage biopharmaceutical company dedicated to transforming cancer care with intelligently designed precision therapies.

Jul 29
3 min

HempMy Pet and Tarleton University announce positive results of their study using CBD on horses

HempMy Pet, a division of HM Health, LLC, offers CBD-infused products for dogs, cats, and horses.

Jul 11
3 min

FIRST IN HUMAN SUBJECTS ENROLLED IN AQUALUNG THERAPEUTICS PHASE 1A STUDY OF ALT-100

Inflammation is a key feature in the pathogenesis of ARDS and the investigational product (IP) ALT-100 is an anti-inflammatory therapeutic..

Jul 9
4 min

Kernal Biologics Raises $25 Million to Advance its mRNA 2.0 Technology for Oncology

There’s a major unmet need to improve outcomes for cancer patients and Kernal Bio has built a strong rational for the use of its novel mRNA

Jun 5
3 min

Imaging Endpoints and ImaginAb partner to supply doses of the CD8 imaging agent for clinical trials

Imaging Endpoints is the world’s largest oncology-focused imaging CRO and has partnered with ImaginAb over the past decade.

May 14
7 min

Mitsubishi Tanabe Pharma America obtains FDA approval of its RADICAVA ORS for the treatment of ALS

We continue to push the boundaries of innovation with RADICAVA ORS, an orally administered option allowing patients flexibility...

May 7
2 min

Sen-Jam Pharmaceutical Enrolls Patients in its COVID Therapy Phase 2 Clinical Trial

Sen-Jam Pharmaceutical, an innovative life sciences company developing a portfolio of revolutionary anti-inflammatories

May 4
3 min

Four pharma solution providers launch Norstella to provide faster patient access to therapies

By launching Norstella, we’re taking the next step toward ensuring tha.t all patients have access to the therapies that they need

Apr 15
4 min

With new funding, Pictor partners with Mobility Health for a SARS-CoV-2 antibody test

“The PictArray™ SARS-CoV-2 Antibody Test is a high performance, all-in-one, NP/SP COVID-19 antibody test with serological differentiation.

Apr 7
2 min

ENDOVASCULAR ENGINEERING CLOSES ON $15 MILLION FOR VENOUS THROMBECTOMY SOLUTIONS

"With the close of this funding we will continue the journey from concept to clinical use/"